DK272889A - Vaccine - Google Patents

Vaccine Download PDF

Info

Publication number
DK272889A
DK272889A DK272889A DK272889A DK272889A DK 272889 A DK272889 A DK 272889A DK 272889 A DK272889 A DK 272889A DK 272889 A DK272889 A DK 272889A DK 272889 A DK272889 A DK 272889A
Authority
DK
Denmark
Prior art keywords
vaccine
Prior art date
Application number
DK272889A
Other languages
English (en)
Other versions
DK272889D0 (da
Inventor
Werner Altenburger
Mary-Helen Binger
Richard Anthony Chizzonite
Richard Allen Kramer
Peter Thomas Lomedico
Stephen J Mcandrew
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK272889D0 publication Critical patent/DK272889D0/da
Publication of DK272889A publication Critical patent/DK272889A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
DK272889A 1988-06-03 1989-06-02 Vaccine DK272889A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20272188A 1988-06-03 1988-06-03

Publications (2)

Publication Number Publication Date
DK272889D0 DK272889D0 (da) 1989-06-02
DK272889A true DK272889A (da) 1989-12-04

Family

ID=22750986

Family Applications (1)

Application Number Title Priority Date Filing Date
DK272889A DK272889A (da) 1988-06-03 1989-06-02 Vaccine

Country Status (22)

Country Link
US (2) US5661015A (da)
EP (1) EP0344808B1 (da)
JP (1) JP3051130B2 (da)
KR (1) KR0156545B1 (da)
CN (3) CN1040126C (da)
AR (1) AR241942A1 (da)
AT (1) ATE120489T1 (da)
AU (1) AU635704B2 (da)
CA (1) CA1340538C (da)
DE (1) DE68921923T2 (da)
DK (1) DK272889A (da)
ES (1) ES2070866T3 (da)
FI (1) FI101453B1 (da)
HU (1) HU212505B (da)
IE (1) IE67544B1 (da)
IL (1) IL90489A0 (da)
MC (1) MC2039A1 (da)
NO (1) NO303876B1 (da)
NZ (1) NZ229377A (da)
PT (1) PT90727B (da)
YU (1) YU47880B (da)
ZA (1) ZA893740B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5174993A (en) * 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
US5279960A (en) * 1984-07-05 1994-01-18 Enzon Corp. 25 KD coccidial antigen of eimeria tenella
US5273901A (en) * 1984-07-05 1993-12-28 Enzon Corp. Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b
US5824656A (en) * 1988-01-15 1998-10-20 Merck & Co., Inc. Recombinant and native group B eimeria tenella immunogens useful as coccidiosis vaccines
DE68927350T2 (de) * 1988-07-05 1997-04-24 British Tech Group Usa Gentechnologisch hergestellter coccidiose-impfstoff
ZA902147B (en) * 1989-03-28 1990-12-28 Akzo Nv Coccidiosis vaccine
EP0403698B1 (en) * 1989-06-21 1993-09-08 Akzo Nobel N.V. Eimeria tenella vaccine
ZA9010461B (en) * 1990-01-26 1991-10-30 Hoffmann La Roche Recombinant coccidiosis vaccines-5-7 eimeria surface antigen
CA2106093A1 (en) * 1991-03-14 1992-09-15 David E. Harwood Recombinant anticoccidial vaccine
US6008342A (en) * 1991-07-12 1999-12-28 Roche Vitamins Inc. DNA encoding eimeria antigen
US5403581A (en) * 1991-07-12 1995-04-04 Hoffmann-La Roche Inc. Coccidiosis vaccines
JP3534774B2 (ja) 1995-06-07 2004-06-07 ファイザー・インク コクシジウム症に対する卵内予防接種
EP0831897B1 (en) 1995-06-07 2001-03-28 Pfizer Inc. In ovo vaccination against coccidiosis
DE69635472T2 (de) * 1995-07-03 2006-04-13 Akzo Nobel N.V. Impfstoff gegen Geflügelkokzidose
EP0921814A4 (en) * 1996-03-29 2001-10-04 Life Technologies Inc Process for increasing the viability and transformation efficiency of bacteria during storage at low temperatures
US6632923B1 (en) 1996-11-27 2003-10-14 Boston Heart Foundation, Inc. Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
ZA200400479B (en) * 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
KR100490669B1 (ko) * 2001-08-30 2005-05-19 (주)아비코아생명공학연구소 조류 콕시듐증을 유발하는 에이메리아 종의 포자소체 표면항원에 대한 ｓｃＦｖ 재조합 항체
IL159397A0 (en) 2001-08-30 2004-06-01 Embrex Inc Improved methods for producing oocysts
JP3995541B2 (ja) * 2002-06-28 2007-10-24 株式会社ゲン・コーポレーション 抗鶏コクシジウム症組成物
DE10330235A1 (de) * 2003-07-04 2005-01-20 Bayer Healthcare Ag Neues Eimeria Gen und Protein sowie deren Verwendung
EP1667702A2 (en) * 2003-09-10 2006-06-14 Baxter International Inc., Baxter Healthcare Corp. Peptides that inhibit complement activation
DE602005021873D1 (de) * 2004-03-12 2010-07-29 Univ Georgia Neues impfstoffadjuvans und dessen herstellung und verwendung
US7087425B2 (en) * 2004-03-31 2006-08-08 Embrex, Inc. Method of purifying oocysts using enzymatic digestion of fecal debris
US20110078828A1 (en) * 2004-09-10 2011-03-31 Guardian Biotechnologies Inc. Multi epitope vaccine for poultry
EP1666489B1 (en) * 2004-12-01 2007-11-21 Zeon Corporation DNA encoding an antigenic protein of eimeria apical membrane antigen 1 and use thereof
CN100398156C (zh) * 2005-11-23 2008-07-02 南京农业大学 用于预防鸡球虫病的免疫调节型dna疫苗
US20080194006A1 (en) * 2007-02-08 2008-08-14 Embrex, Inc. Methods of releasing sporocysts from oocysts using controlled shear forces
US11701683B2 (en) 2010-12-22 2023-07-18 The Procter & Gamble Company Methods for foil stamping parts having asymmetrical edges
RU2764802C2 (ru) 2016-12-22 2022-01-21 Интервет Интернэшнл Б.В. ВАКЦИНА ПРОТИВ Eimeria С УЛУЧШЕННОЙ ЭФФЕКТИВНОСТЬЮ
CA3142023A1 (en) * 2019-05-28 2020-12-03 Case Western Reserve University Compositions and methods for preserving dna methylation

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
DE2814039C3 (de) 1978-03-31 1981-02-19 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig Verfahren zur Herstellung von Hybrid-Bakterien
US4710377A (en) * 1983-08-19 1987-12-01 American Cyanamid Company Antigens and monoclonal antibodies reactive against sporozoites of Eimeria spp.
EP0135712A3 (en) * 1983-08-19 1987-05-27 American Cyanamid Company Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp.
US4650676A (en) 1983-08-19 1987-03-17 American Cyanamid Company Antigens and monoclonal antibodies reactive against merozoites of Eimeria spp.
EP0135073A3 (en) * 1983-08-19 1987-05-27 American Cyanamid Company Antigens and monoclonal antibodies reactive against merozites of eimeria spp.
US4874705A (en) * 1985-05-16 1989-10-17 Solvay & Cie, S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
US5187080A (en) * 1984-06-05 1993-02-16 Solvay & Cie S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
CA1340520C (en) * 1984-06-05 1999-05-04 Karel Z. Newman Jr. Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix
US4639372A (en) 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
US5273901A (en) * 1984-07-05 1993-12-28 Enzon Corp. Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b
WO1986000528A1 (en) * 1984-07-05 1986-01-30 Genex Corporation Cloned gene and method for making and using the same
ATE73494T1 (de) * 1985-12-03 1992-03-15 Solvay Antigene proteine und diese enthaltende impfstoffe zur verhuetung von kokzidiose.
EP0241139A3 (en) * 1986-03-13 1989-04-19 Merck & Co. Inc. Anti-idiotypic vaccine for coccidiosis
US5496550A (en) * 1986-08-14 1996-03-05 Chilwalner Method of reducing the output of Eimeria oocysts from a newborn chick
ATE145245T1 (de) * 1987-03-06 1996-11-15 Amgen Boulder Inc Polypeptide zur verwendung bei der diagnose von kokkidien-infektion und rekombinant-dns, verfahren zur herstellung derselben
EP0315073A2 (en) * 1987-11-02 1989-05-10 Matsushita Electric Industrial Co., Ltd. A composition for pattern forming materials
NZ227597A (en) * 1988-01-15 1991-11-26 Merck & Co Inc Eimeria tenella group b immunogens and their production
NZ227595A (en) * 1988-01-15 1991-11-26 Merck & Co Inc Recombinant production of eimeria tenella antigens and their use
AU620366B2 (en) * 1988-02-12 1992-02-20 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated response and method of producing the same
DE3926461A1 (de) * 1989-07-15 1991-01-24 Suttner Gmbh & Co Kg Ventilpistole, insbesondere fuer ein hochdruckreinigungsgeraet

Also Published As

Publication number Publication date
CA1340538C (en) 1999-05-11
NO892251D0 (no) 1989-06-02
YU113889A (en) 1991-10-31
ZA893740B (en) 1990-02-28
HU212505B (en) 1996-07-29
FI101453B (fi) 1998-06-30
PT90727B (pt) 1994-11-30
IE891812L (en) 1989-12-03
EP0344808A1 (en) 1989-12-06
HUT52963A (en) 1990-09-28
IE67544B1 (en) 1996-04-17
NZ229377A (en) 1992-06-25
US5661015A (en) 1997-08-26
PT90727A (pt) 1989-12-29
CN1038837A (zh) 1990-01-17
AR241942A1 (es) 1993-01-29
IL90489A0 (en) 1990-01-18
US20030175311A1 (en) 2003-09-18
DE68921923T2 (de) 1995-08-10
ATE120489T1 (de) 1995-04-15
DE68921923D1 (de) 1995-05-04
FI101453B1 (fi) 1998-06-30
CN1186695A (zh) 1998-07-08
NO303876B1 (no) 1998-09-14
AU3601689A (en) 1989-12-07
EP0344808B1 (en) 1995-03-29
FI892714A0 (fi) 1989-06-02
KR0156545B1 (ko) 1998-11-16
JPH037594A (ja) 1991-01-14
YU47880B (sh) 1996-05-20
JP3051130B2 (ja) 2000-06-12
CN1076204C (zh) 2001-12-19
NO892251L (no) 1989-12-04
DK272889D0 (da) 1989-06-02
MC2039A1 (fr) 1990-05-30
CN1187368A (zh) 1998-07-15
CN1040126C (zh) 1998-10-07
FI892714A (fi) 1989-12-04
KR910000183A (ko) 1991-01-29
CN1077438C (zh) 2002-01-09
ES2070866T3 (es) 1995-06-16
AU635704B2 (en) 1993-04-01

Similar Documents

Publication Publication Date Title
DK272889A (da) Vaccine
KR900011476A (ko) 백신 제제
ATA901789A (de) Somatostatinpeptid
BR8806093A (pt) Trepano
DE3752263T2 (de) Impfstoffe
ATA900689A (de) Calcitoninpeptide
ATA172889A (de) Furanderivate
DK540389A (da) Immunstimulerende praeparat
DK189788D0 (da) Vaccine
KR890700356A (ko) 신규의 백신
DE68926597D1 (de) Mikrorechner
BR8902098A (pt) Eletrolisador
BR8906898A (pt) Jamela
DK375488D0 (da) Vaccine
DK606288D0 (da) Praeparat
DE68926367D1 (de) Hydroxymethylcyclobutylpurine
DK343689A (da) Herbicidt praeparat
DD277186A3 (de) Waelzlagerseparator
DK653388A (da) Vaccine
IT216207Z2 (it) Taglia tigella
BR6800515U (pt) Endoscopio
BR6800913U (pt) Trailer-sanitarios publico
BR6801036U (pt) Rechaud
BR6801307U (pt) Boneco-luva
BR6801330U (pt) Caixa-arquivo

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment